Intuitive Surgical price target raised to $300 from $250 at Mizuho

Mizuho analyst Anthony Petrone raised the firm’s price target on Intuitive Surgical to $300 from $250 and keeps a Neutral rating on the shares. The company reported a Q1 beat but the bigger story was the sharp reversal in global procedures to up 26% versus the 11% baked into prevailing Street expectations, the analyst tells investors in a research note. With momentum in general surgery expected to continue, the company raised its full-year procedure outlook to 18%-21%, the firm says. However, it still recommends waiting for a better entry point into the shares.